Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo

Area of Science:

• Physiology
• Molecular Biology
• Inflammation Research

Background:

• Nitric oxide (NO) is a known regulator of blood flow.
• The precise role of NO, particularly endothelial nitric oxide synthase (eNOS), in regulating microvascular permeability during inflammation remains incompletely understood.

Purpose of the Study:

• To investigate the essentiality of eNOS in baseline and inflammation-induced microvascular permeability.
• To determine if molecular inhibition of eNOS affects hyperpermeability responses.
• To clarify the role of inducible nitric oxide synthase (iNOS) in these processes.

Main Methods:

• Utilized eNOS-deficient (eNOS-/-) mice and wild-type controls.
• Administered platelet-activating factor (PAF) as a pro-inflammatory agent.
• Measured microvascular permeability using integrated optical intensity (IOI) in cremaster muscle and mesentery.
• Tested the effect of AP-Cav, a molecular inhibitor of eNOS, on hyperpermeability.

Main Results:

• Baseline microvascular permeability was not dependent on eNOS.
• PAF significantly increased permeability in wild-type mice, but this response was markedly reduced in eNOS-/- mice.
• iNOS-deficient mice showed similar PAF-induced hyperpermeability as wild-type mice.
• Administration of AP-Cav effectively blocked PAF-induced hyperpermeability.

Conclusions:

• eNOS is essential for the hyperpermeability response to inflammatory stimuli like PAF.
• iNOS does not play a significant role in baseline or PAF-induced microvascular permeability.
• Caveolin-1 scaffolding domain (AP-Cav) can inhibit eNOS-mediated regulation of microvascular permeability in vivo.
• eNOS is established as a key regulator of microvascular permeability during inflammation.